Trials / Recruiting
RecruitingNCT05828628
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
A Prospective Imaging and Translational Tissue Study in CNS Lymphoma to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (estimated)
- Sponsor
- Royal Marsden NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective imaging and translational tissue study in CNS lymphoma to enable further disease characterisation and the development of potential predictive and prognostic biomarkers.
Detailed description
As a single centre exploratory study, this trial will recruit patients with newly diagnosed primary CNS lymphoma and will look at the molecular aspects of the disease in the tissue collection and imaging response assessments using CCA with respect to progression free survival.
Conditions
Timeline
- Start date
- 2023-09-18
- Primary completion
- 2028-09-01
- Completion
- 2031-09-01
- First posted
- 2023-04-25
- Last updated
- 2025-06-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05828628. Inclusion in this directory is not an endorsement.